Rilotumumab
CAS: 872514-65-3
Ref. TM-T76758
1mg | 237.00 € | ||
5mg | 620.00 € | ||
10mg | 993.00 € | ||
25mg | 1,476.00 € | ||
50mg | 1,977.00 € | ||
100mg | 2,673.00 € |
Product Information
- AMG 102
Rilotumumab (AMG 102) is a monoclonal antibody targeting hepatocyte growth factor that inhibits HGF/ MET-driven signaling. Rilotumumab has antitumor effects and can be used to study castration-resistant prostate cancer (CRPC) and gastric cancer.
Chemical properties
Technical inquiry about: TM-T76758 Rilotumumab
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.